Vascular and connective tissue diseases in the paediatric world

Related Experiment Videos

F Falcini1

  • 1Department of Paediatrics, Rheumatology Unit, University of Florence, Firenze, Italy. falcini@unifi.it

Lupus
|March 5, 2004
PubMed

Insights

Pediatric rheumatologists face challenges with connective tissue diseases. New immunosuppressant therapies and aggressive treatments improve outcomes for juvenile lupus and dermatomyositis, while other conditions like Kawasaki disease and Henoch-Schönlein purpura require ongoing research.

Area of Science:

  • Pediatric Rheumatology
  • Connective Tissue Diseases
  • Immunology

Background:

  • Connective tissue diseases present ongoing challenges in pediatric rheumatology despite recent advances.
  • Current therapeutic regimens, while improved, necessitate further refinement for optimal patient outcomes.

Purpose of the Study:

  • To review current therapeutic strategies for various pediatric connective tissue diseases.
  • To highlight areas of therapeutic consensus and ongoing debate in pediatric rheumatology.
  • To suggest optimized treatment approaches for improved survival and reduced organ damage.

Main Methods:

  • Review of existing literature on classification, outcomes, and therapeutic regimens for pediatric connective tissue diseases.
  • Analysis of treatment effectiveness and controversies for specific conditions including juvenile SLE, dermatomyositis, Henoch-Schönlein purpura, Kawasaki disease, and polyarteritis nodosa.

Main Results:

  • Corticosteroids remain first-line for juvenile SLE, but immunosuppressants are suggested for better survival and less organ damage.
  • Aggressive treatment with corticosteroids and methotrexate improves prognosis in juvenile dermatomyositis.
  • Treatment for Henoch-Schönlein purpura and Kawasaki disease shows ongoing debate, particularly regarding corticosteroid use and renal involvement.
  • Polyarteritis nodosa requires aggressive corticosteroid and immunosuppressant therapy, while cutaneous polyarteritis needs infection control and penicillin prophylaxis.

Conclusions:

  • A shift towards immunosuppressant therapy is warranted for juvenile SLE to improve long-term outcomes.
  • Optimized and aggressive treatment strategies are crucial for improving prognosis in juvenile dermatomyositis.
  • Further research is needed to establish definitive treatment guidelines for Henoch-Schönlein purpura and Kawasaki disease, especially concerning corticosteroid efficacy and management of incomplete diagnostic criteria cases.
  • Effective management of polyarteritis nodosa and cutaneous polyarteritis involves aggressive immunosuppression and infection control, respectively.

Related Concept Videos

Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fluid Connective Tissues: Blood and Lymph01:20

Fluid Connective Tissues: Blood and Lymph

Blood and lymph are fluid connective tissues. They contain cells, also known as formed elements, circulating in a liquid extracellular matrix, the plasma. The formed elements are derived from hematopoietic stem cells in the bone marrow. Blood and lymph connect all vital parts and carry nutrients, oxygen, and other essential molecules like antibodies.
Blood
The blood flows through blood vessels— arteries, capillaries, and veins. Blood plasma is primarily made of proteins, solutes, and water.
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...